These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combined serotonergic-cholinergic lesions do not disrupt memory in rats. Sahgal A, Keith AB. Pharmacol Biochem Behav; 1993 Aug; 45(4):995-1001. PubMed ID: 8415844 [Abstract] [Full Text] [Related]
5. Mnemonic deficits in the double Y-maze are related to the effects of nucleus basalis injections of ibotenic and quisqualic acid on choline acetyltransferase in the rat amygdala. Beninger RJ, Kühnemann S, Ingles JL, Jhamandas K, Boegman RJ. Brain Res Bull; 1994 Aug; 35(2):147-52. PubMed ID: 7953771 [Abstract] [Full Text] [Related]
6. Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats. Mandel RJ, Thal LJ. Psychopharmacology (Berl); 1988 Aug; 96(3):421-5. PubMed ID: 3146779 [Abstract] [Full Text] [Related]
8. Reversal of learning and memory impairments following lesion of the nucleus basalis magnocellularis (NBM) by concurrent noradrenergic depletion using DSP4 in the rat. Moran PM, LeMaître MH, Philouze V, Reymann JM, Allain H, Leonard BE. Brain Res; 1992 Nov 13; 595(2):327-33. PubMed ID: 1281740 [Abstract] [Full Text] [Related]
9. Nucleus basalis lesions: implication of basoamygdaloid cholinergic pathways in memory. Mallet PE, Beninger RJ, Flesher SN, Jhamandas K, Boegman RJ. Brain Res Bull; 1995 Nov 13; 36(1):51-6. PubMed ID: 7882049 [Abstract] [Full Text] [Related]
10. Serotonin influences the behavioral recovery of rats following nucleus basalis lesions. Markowska AL, Wenk GL. Pharmacol Biochem Behav; 1991 Apr 13; 38(4):731-7. PubMed ID: 1651515 [Abstract] [Full Text] [Related]
13. Cholinergic receptor blockade in prefrontal cortex and lesions of the nucleus basalis: implications for allocentric and egocentric spatial memory in rats. Nieto-Escámez FA, Sánchez-Santed F, de Bruin JP. Behav Brain Res; 2002 Aug 21; 134(1-2):93-112. PubMed ID: 12191796 [Abstract] [Full Text] [Related]
14. Physostigmine, but not 3,4-diaminopyridine, improves radial maze performance in memory-impaired rats. Beninger RJ, Wirsching BA, Mallet PE, Jhamandas K, Boegman RJ. Pharmacol Biochem Behav; 1995 Aug 21; 51(4):739-46. PubMed ID: 7675853 [Abstract] [Full Text] [Related]
18. Nicotine-induced catecholamine synthesis after lesions to the dorsal or ventral noradrenergic bundle. Mitchell SN, Brazell MP, Schugens MM, Gray JA. Eur J Pharmacol; 1990 Apr 25; 179(3):383-91. PubMed ID: 2114296 [Abstract] [Full Text] [Related]
19. Kangenkaryu prevents the decrease of cholinergic markers following the nucleus basalis magnocellularis lesion. Takahashi M, Sugaya K, Kubota K. Jpn J Pharmacol; 1992 Nov 25; 60(3):307-10. PubMed ID: 1491519 [Abstract] [Full Text] [Related]
20. Scopolamine-disruption of radial arm maze performance: modification by noradrenergic depletion. Decker MW, Gallagher M. Brain Res; 1987 Aug 04; 417(1):59-69. PubMed ID: 3620979 [Abstract] [Full Text] [Related] Page: [Next] [New Search]